B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.520 -0.010 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corp ADR

< Previous 1 2 3 4 5 6 7 8 Next >
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
SHAREHOLDER ALERT: HEPS BMRN AMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
AMRN ALERT: Amarin Corporation plc Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Analyzing Amarin Corp's Unusual Options Activity
Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti... 
Via Benzinga
Analyzing Amarin Corp's Unusual Options Activity
Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti... 
Via Benzinga
CORRECTING and REPLACING AMARIN CLASS ACTION NOTICE: The Schall Law Firm Files Securities Fraud Lawsuit Against Amarin Corporation, plc
From The Schall Law Firm
Via Business Wire
AMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Amarin Corporation PLC and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
AMARIN CLASS ACTION NOTICE: The Schall Law Firm Files Securities Fraud Lawsuit Against Amarin Corporation, plc
From The Schall Law Firm
Via Business Wire
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Cramer Shares His Thoughts On Dynavax, Nucor And Amarin
On CNBC's "Mad Money Lightning Round," Jim Cramer said Dynavax Technologies Corporation (NASDAQ: DVAX) is good. He loves the immuno drug stories. Cramer said you are... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE: 
Via Benzinga
Amarin Stock Moves Higher As Vascepa Cuts Risk Of Heart Attacks
Amarin Corporation plc (NASDAQ: AMRN) announced additional data on Vascepa/Vazkepa (icosapent ethyl) in patients with prior heart attack, known as myocardial... 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
Why Amarin Is Soaring Today
The pharmaceuticals company is showing surprising resilience in the face of competition. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Amarin (AMRN) Q2 2021 Earnings Call Transcript
AMRN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Amarin Q2 Earnings
Shares of Amarin Corp (NASDAQ:AMRN) rose 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the... 
Via Benzinga
Understanding Amarin Corp's Unusual Options Activity
Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $4.22. Sentiment: BEARISH Option... 
Via Benzinga
Why Amarin Fell Again Today
Another Vascepa generic is launched in the U.S. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide
Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
31 Stocks Moving In Monday's Mid-Day Session
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)... 
Via Benzinga
Why Amarin Stock Is Sinking Today
The biotech's attempt to revive Vascepa's U.S. patent protection appears to be at a dead end. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Understanding Amarin Corp's Unusual Options Activity
Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the option alert. Sentiment: BEARISH Option Type... 
Via Benzinga
Market Briefing For Tuesday, Jun. 8
Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first. 
Via Talk Markets
Why Amarin Trounced the Market on Tuesday
Investors reacted positively to a company presentation at an industry convention. 
Via The Motley Fool
Why Amarin Stock Is Tumbling Today
An analyst downgraded the drugmaker. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021
Upgrades Craig-Hallum upgraded the previous rating for ShotSpotter Inc (NASDAQ:SSTI) from Hold to Buy. For the first quarter, ShotSpotter had an EPS of $0.02, compared to... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading. Needham cut BigCommerce... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.